ROLE OF LOW-DOSE AZITHROMYCIN IN THE MANAGEMENT OF CYSTIC BRONCHIECTASIS: A CASE SERIES
Sari
Kata Kunci
Teks Lengkap:
PDFReferensi
Barker AF, Brody SL. Bronchiectasis. In: Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM, editors. Fishman’s Pulmonary Disease and Disorder. Fifth edit. New York: Mc GrawHill; 2015.p. 1637-54
Pasteur MC, Bilton D, Hill AT. British thoracic society guideline for non-CF bronchiectasis. Thorax. 2010;65(SUPPL. 1).
Quint JK, Millett ERC, Joshi M, Navaratnam V, Thomas SL, Hurst JR, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: A population-based cohort study. European Respiratory Journal. 2016 Jan 1;47(1):186–93.
Hill AT, Sullivan AL, Chalmers JD, de Soyza A, Elborn S, Floto A, et al. On behalf of the British Thoracic Society.
Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Vol. 50, European Respiratory Journal. European Respiratory Society; 2017.
McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Vol. 188, American Journal of Respiratory and Critical Care Medicine. 2013. p. 647–56.
Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EHJ, Koppers RJH, et al. Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial [Internet]. Available from: http://www.jama
Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. European Respiratory Journal. 2015 May 1;45(5):1446–62.
King PT. The pathophysiology of bronchiectasis. Vol. 4, International journal of chronic obstructive pulmonary disease. 2009. p. 411–9.
Chalmers JD, Sethi S. Raising awareness of bronchiectasis in primary care: Overview of diagnosis and management strategies in adults. Vol. 27, npj Primary Care Respiratory Medicine. Nature Publishing Group; 2017.
Al-Jahdali H, Alshimemeri A, Mobeireek A, Albanna A, al Shirawi N, Wali S, et al. The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis. Ann Thorac Med. 2017 Jul 1;12(3):135–61.
Contarini M, Finch S, Chalmers JD. Bronchiectasis: a case-based approach to investigation and management. Available from: http://ow.ly/RDF730koTxu
Wong C, Jones S. Oxidative stress and macrolides in bronchiectasis - Exhaling few clues. Vol. 18, Respirology. 2013. p. 1037–8.
Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, et al. Azithromycin for prevention of exacerbations in non-cystic fi brosis bronchiectasis (EMBRACE): A randomised, double-blind, placebo-controlled trial. The Lancet. 2012;380(9842):660–7.
Serisier DJ, Megan Martin FL, Michael McGuckin BA, Lourie R, Alice Chen FC, Brain B, et al. Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BLESS Randomized Controlled Trial [Internet]. Available from: https://jamanetwork.com/
DOI: https://doi.org/10.33024/jikk.v10i3.9540
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc4.footer##
Pendidikan Dokter Universitas Malahayati Lampung
![Creative Commons License](https://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.